Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SightLine Partners is a venture capital and private equity firm based in Bloomington, Minnesota, that specializes in secondary direct investments within the medical technology and healthcare sectors. The firm manages the SightLine Healthcare Opportunity Funds, which are designed to provide liquidity and financing alternatives to existing investors in late-stage, often revenue-generating, companies. Their investment strategy focuses on companies with established clinical evidence and near-term exit potential across medtech, diagnostics, and biotechnology. SightLine's portfolio has included notable companies such as Lyra Therapeutics, CVRx, and Colorescience, supporting them through critical clinical and commercial milestones.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sightline Healthcare Opportunity.